ERCC2 gene single-nucleotide polymorphism as a prognostic factor for locally advanced head and neck carcinomas after definitive cisplatin-based radiochemotherapy

Identifying patients with locally advanced head and neck carcinoma on high risk of recurrence after definitive concurrent radiochemotherapy is of key importance for the selection for consolidation therapy and for individualized treatment intensification. In this multicenter study we analyzed recurre...

Descripción completa

Detalles Bibliográficos
Autores principales: Guberina, Maja, Sak, Ali, Pöttgen, Christoph, Tinhofer-Keilholz, Ingeborg, Budach, Volker, Balermpas, Panagiotis, Von der Grün, Jens, Rödel, Claus Michael, Gkika, Eleni, Grosu, Anca-Ligia, Abdollahi, Amir, Debus, Jürgen, Belka, Claus, Pigorsch, Steffi, Combs, Stephani E., Mönnich, David, Zips, Daniel, De-Colle, Chiara, Welz, Stefan, Linge, Annett, Lohaus, Fabian, Baretton, Gustavo, Gauler, Thomas, Baumann, Michael, Krause, Mechthild, Schuler, Martin, Bankfalvi, Agnes, Höing, Benedikt, Lang, Stephan, Stuschke, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7840506/
https://www.ncbi.nlm.nih.gov/pubmed/32546699
http://dx.doi.org/10.1038/s41397-020-0174-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7840506/
https://www.ncbi.nlm.nih.gov/pubmed/32546699
http://dx.doi.org/10.1038/s41397-020-0174-1

Ejemplares similares